- Home
- CDNA vs NFGC Comparison
CDNA vs NFGC Comparison
Compare CDNA & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- NFGC
- Stock Information
- Founded
- CDNA 1998
- NFGC 2016
- Country
- CDNA United States
- NFGC Canada
- Employees
- CDNA N/A
- NFGC N/A
- Industry
- CDNA Medical Specialities
- NFGC Precious Metals
- Sector
- CDNA Health Care
- NFGC Basic Materials
- Exchange
- CDNA Nasdaq
- NFGC Nasdaq
- Market Cap
- CDNA 712.2M
- NFGC 588.1M
- IPO Year
- CDNA 2014
- NFGC N/A
- Fundamental
- Price
- CDNA $15.19
- NFGC $2.29
- Analyst Decision
- CDNA Buy
- NFGC Strong Buy
- Analyst Count
- CDNA 8
- NFGC 1
- Target Price
- CDNA $26.86
- NFGC $5.00
- AVG Volume (30 Days)
- CDNA 1.3M
- NFGC 1.8M
- Earning Date
- CDNA 11-03-2025
- NFGC 11-11-2025
- Dividend Yield
- CDNA N/A
- NFGC N/A
- EPS Growth
- CDNA N/A
- NFGC N/A
- EPS
- CDNA 1.00
- NFGC N/A
- Revenue
- CDNA $340,826,000.00
- NFGC N/A
- Revenue This Year
- CDNA $12.73
- NFGC N/A
- Revenue Next Year
- CDNA $11.90
- NFGC N/A
- P/E Ratio
- CDNA $15.23
- NFGC N/A
- Revenue Growth
- CDNA 14.72
- NFGC N/A
- 52 Week Low
- CDNA $10.96
- NFGC $0.93
- 52 Week High
- CDNA $32.76
- NFGC $2.81
- Technical
- Relative Strength Index (RSI)
- CDNA 60.38
- NFGC 60.02
- Support Level
- CDNA $14.28
- NFGC $2.27
- Resistance Level
- CDNA $15.21
- NFGC $2.58
- Average True Range (ATR)
- CDNA 0.60
- NFGC 0.13
- MACD
- CDNA 0.02
- NFGC 0.00
- Stochastic Oscillator
- CDNA 72.48
- NFGC 53.91
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).